CCAA and Chapter 11 courts back incentive plans for drug company management
Aralez primarily produces cardiovascular drugs (Credit: iStock.com/yodiyim)
Courts in Canada and the US have approved incentive plans for the senior management of Canadian pharmaceutical company Aralez, designed to reduce debtor-in-possession funding for its Chapter 11 and Companies Creditor Arrangement Act proceedings.
To read more
Subscribe to Global Restructuring Review
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Register now
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Restructuring Review experts.
Subscribe now